FindTrial
Sign In

Azzalure

DRUG4 trials

Sponsors

Stichting Amsterdam UMC, Galderma R&D, Ipsen

Conditions

Facial Aesthetic TreatmentGlabellar Frown LinesGlabellar frown rhytides (wrinkles).Moderate Upper Facial LinesSevere Upper Facial Lines

Phase 1

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines.
TerminatedNCT04736745
IpsenModerate Upper Facial Lines, Severe Upper Facial Lines
Start: 2021-02-10End: 2022-10-28Updated: 2023-07-14

Phase 4

A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines
CompletedNCT02108158
Galderma R&DGlabellar Frown Lines
Start: 2014-04-30End: 2014-12-31Updated: 2022-08-25
Safety and Efficacy of Treatment With Azzalure, Restylane/Emervel Filler and Restylane Skinbooster
CompletedNCT02297503
Galderma R&DFacial Aesthetic Treatment
Start: 2014-11-30End: 2016-12-31Updated: 2022-08-26
Head-to-Head Comparison of the Efficacy and Safety of All Commercially Available Botulinum Neurotoxin Type A Products for the Treatment of Glabellar Rhytides: A Multicenter, Triple-Blind, Randomized Controlled Trial
Not yet recruitingCTIS2024-516865-35-01
Stichting Amsterdam UMCGlabellar frown rhytides (wrinkles).
Target: 390Updated: 2025-09-30